Ovarian tissue cryopreservation and transplantation in menopause: new perspective of therapy in postmenopausal women and the importance of ethical and legal frameworks

Menopausal transition entails a progressive decrease in hormone production by the ovaries that lead to important physical and psychological changes that could significantly affect quality of life. Hormone replacement therapy (HRT) administered from the onset of menopausal symptoms usually improves quality of life and life expectancy. Nevertheless, it is not risk-free. Ovarian tissue cryopreservation (OTC) has been investigated as a potential new strategy for delaying menopause and/or to avoid HRT. This review analyzes the critical points of HRT to assess whether OTC and subsequent reimplantation can affect postmenopausal management. We assessed available randomized clinical trials in PubMed, Cochrane Library, ISI web of science, and Scopus from August 2021 to November 2022, including studies and trials evaluating the efficacy of OTC in both cancer and menopausal patients, the efficacy of freezing techniques and the possible clinical scenarios that OTC can open, even from the standpoint of legal and ethical issues arising as such innovative techniques become mainstream. Lower duration of the graft and efficacy on estrogen secretions at a physiological and safer concentration of estrogen than conventional HRT based on hormonal supplements. OTC can reportedly trigger estrogen secretions at a lower and safer physiological concentration than conventional HRT. OTC and subsequent reimplantation remain a valid fertility-sparing approach in patients undergoing gonadotoxic treatments. Further studies are needed to better evaluate its safety and efficacy within postmenopausal therapy management and in order to lay out widely shared and evidence-based guidelines and best practices and perform such novel and innovative techniques in a legally and ethically safe fashion, in the best interest of patients and healthcare professionals.

The autobiographical narrative as a damage assessment means: injuries to profound subjective sensitivities - personalization and objectivization of medicolegal relevance

The article aims to outline and expound upon the impairing aspects of an acoustic lesion involving deafness, analyzing the disabling effects on all aspects of the daily life of the injured person, even in the absence of permanent psychic damage that can be nosographically categorized. Such a form of additional damage, which can hardly be quantified, is certainly immaterial and perhaps cannot even be qualified as biological; although it still falls within the realm of psychic functioning, it must be adequately framed by the forensic doctor, in order to enable the Judge to issue a coherently motivated ruling, fully contextualized within the clinical reality of the patient. This task is strictly medicolegal in nature, and requires the professional to carry out in-depth work thoroughly based on listening for the purpose of providing the courts with a faithful representation.